$BIXT interview short on #BirdFlu #H5N1 #Influenza #H1N1 #covid19 #galectin antagonist - feasibility discussion Emerging Growth Conference youtube.com/watch?v=cj5yrp…

$BIXT CCO - #BirdFlu #H5N1 Article LinkedIn Mike Sheikh #galectin3 #galectin #galectinantagonist #broadspectrumantiviral #antiviral #vaccines #vaccination $TSN $CALM linkedin.com/pulse/bird-flu…

Bioxytran CEO Dr. David Platt will be featured at the Emerging Growth Conference this Thursday, June 13, 2024, at 1:10 PM Eastern Time. $BIXT Sign up here to join the interview: tinyurl.com/f9ewbd9s

Please join BIOXYTRAN CCO Michael Sheikh at the Emerging Growth Conference tomorrow, July 18, at 1:45 PM as he discusses Bioxytran's Universal Oxygen Carrier JV. $BIXT Register for the conference here: tinyurl.com/23z643v6

$BIXT, a clinical stage biotechnology company developing oral and IV drugs to treat COVID-19, other viral diseases, & stroke, announces a Joint Venture with the Heme Foundation to develop a Universal Oxygen Carrier as an alternative to blood transfusions. tinyurl.com/mr2ezypk

Bioxytran CCO Mike Sheikh will take on cancer metastasis in his interview at the Emerging Growth Conference on Thursday, Sept. 26, 2025 from 11:25 AM to 11:55 AM Eastern. Please click the registration link: tinyurl.com/3hpkm9j8

Bioxytran CCO Mike Sheikh will talk about the Medical Breakthrough in #virology & LinkedIn article on #cancer in his interview Emerging Growth Conference on Thursday, October 31, 2024 from 1:10 - 1:40 PM Eastern. Click to register: tinyurl.com/4rhsndbm

A Techwatch Light meeting, hosted by Biomedical Advanced Research & Development Authority (BARDA), introduced $BIXT to government to help facilitate/direct $BIXT to finding programs within the government capable of funding development initiatives. tinyurl.com/5654s282

$BIXT #Cancer Preprint Reveals potential to enhance most Immunotherapy drugs. #galectin3 is a pivotal driver of cancer disease. #galectinantagonists to aid in treatment resistance #metastasis Mike Sheikh globenewswire.com/news-release/2…

BIOXYTRAN $BIXT announced it entered into an SPA with TRITON FUNDS LP for $1,600,000. READ THE FULL PRESS RELEASE: tinyurl.com/4xcfdnur

$BIXT CCO attending Precision Medicine World Conference #PMWC25 to network w/ Big & Small Pharma. Contact Mike Sheikh on overcoming Immune Checkpoint Resistance in #Cancer & reality of Broad Spectrum Antivirals defeating Quadremic outbreaks. Speakers: $NVDA Jensen Huang & Nobel Laureat @carolynBertozzi

$BIXT is developing a novel class of Broad Spectrum Antivirals. Demonstrated in vitro and/or clinical efficacy in 4 different viral families to date. Existing #antivirals confined to just one family at best. Superior MOA is Entry Inhibition. #COVID19 #RSV #FLU #BirdFlu #Shingles

$BIXT News Groundbreaking Treatment to Combat #BirdFlu in Egg Laying Chickens Potentially Saving Billions. New H2O soluble #Galectin Antagonist considered in preclinical trials. Potential to achieve rapid containment of #H5N1 outbreaks. bioxytraninc.com/press-releases…

$BIXT Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens. READ THE FULL PRESS RELEASE HERE! tinyurl.com/43wv43w7

$BIXT CCO Mike Sheikh Interview and Business Update on Emerging Growth 12:35 PM EST. Get Ready Register NOW! #galectinscience #COVID19 #RSV #H5N1 #H1N1 goto.webcasts.com/starthere.jsp?…

$BIXT CCO Mike Sheikh Interview and Business Update on Emerging Growth 11:25 AM EST. Get Ready Register NOW! #virology #bigpharmadeals #galectinscience #COVID19 #RSV #H5N1 #H1N1 goto.webcasts.com/starthere.jsp?…

$BIXT announced UGA confirmed the antiviral PHM23 was to be included in its grant submission to the U.S. Department of Agriculture’s (USDA) $100 million Highly Pathogenic Avian Influenza (HPAI) Poultry Innovation Grand Challenge. READ FULL PRESS RELEASE: tinyurl.com/mwmjcj6d

$BIXT announced the publication of Prof. Mayevsky’s book "The Mongolian Gerbil Brain" which serves as a cornerstone for Bioxytran’s clinical development program of the universal oxygen carrier in ischemic stroke and Alzheimer’s disease. Press release: tinyurl.com/ycdbt2b4

Bioxytran ($BIXT) Secures a Source of GMP Quality Camel Hemoglobin. 1) First use of camel hemoglobin as a universal oxygen carrier. 2) Unique properties make it an ideal ingredient for oxygen transport. READ THE FULL PRESS RELEASE: tinyurl.com/2s4xkzu8 🔗 IN PROFILE